• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

About april@madhedgefundtrader.com

This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2301 entries already.

Entries by april@madhedgefundtrader.com

Tech Letter

May 1, 2024 - Quote of the Day

“The most terrifying words in the English language are: I'm from the government and I'm here to help.” – Said Former US President Ronald Reagan  

Tech Alert

Trade Alert - (ROKU) May 1, 2024 - BUY

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

Jacque's Post

May 1, 2024

  ( THE YEN IS FACING A DILEMMA) May 1, 2024   Hello everyone, Welcome to May, and what could be a continuation of the market behaviour we saw in April.   The market is in the doldrums about what the Fed might say on Wednesday. Investors are already interpreting and theorizing possible outcomes, hence

Diary, Newsletter, Summary

May 1, 2024

Global Market Comments May 1, 2024 Fiat Lux   Featured Trade: (SEVEN REASONS TO BUY CHARLES SCHWAB), (SCHW), (TLT), (GS), (MS), (C), (BAC), (TESTIMONIAL), (TAKING A BITE OUT OF STEALTH INFLATION)  

Diary, Newsletter

Seven Reasons to Buy Charles Schwab

Looking for a financial to add to your tech-heavy portfolio? I think the nimble investor can pick up shares of online broker Charles Schwab (SCHW) and gain an outsized return. That’s assuming that the current correction in the stock market remains in single digits, and doesn’t explode into a full-blown bear market. There are many

Diary, Newsletter, Testimonials

Testimonial

Dear John, I loved your trades this year! 10% plus in a day? I’ll take as many of those as you can dream up. And pulling this off in this boring market is incredible. After reading BS and extreme negativity in my other newsletters all day long, you are a breath of fresh air. Keep

Diary, Newsletter

Taking a Bite Out of Stealth Inflation.

When I visited the local fire station in the spring, I was snared by some uniformed pre-teens, backed by beaming mothers behind a card table selling Girl Scout cookies. I was a pushover. I walked away with a bag of Thin Mints, Lemon Chalet Creams, Do-Si-Dos, and Tagalongs. I have to confess a lifetime addiction

Trade Alert

Trade Alert - (GLD) April 30, 2024 - BUY

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

Biotech Letter

April 30, 2024

Mad Hedge Biotech and Healthcare Letter April 30, 2024 Fiat Lux   Featured Trade: (HITTING CTRL+ALT+DELETE ON DRUG R&D) (DNA), (GOOGL), (JNJ), (ILMN), (JNJ), (ALTO), (GROIV)

Biotech Letter

Hitting Ctrl+Alt+Delete On Drug R&D

Forget your classic biotech launch story. One of 2024's most lavishly funded biotech upstarts is taking a massively ambitious swing at reinventing the entire drug development process. I'm talking AI, venture billions, and some serious star power all rolled into one wild capital extravaganza. The company behind this cash-flushed disruption bid is Xaira Therapeutics. And

Page 145 of 227«‹143144145146147›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top